Bio-Works Technologies AB is a pioneering entity within the biotechnology sector, specializing in the development and commercialization of high-performance chromatography resins. These resins are essential components used in the purification and separation phases of industrial and laboratory processes, particularly in biopharmaceutical manufacturing. By providing superior products designed for protein purification and other separation needs, Bio-Works Technologies AB plays a critical role in the production of biologics, vaccines, and diagnostics. The company's offerings are distributed globally and serve industries including healthcare, life sciences, and environmental solutions. Headquartered in Sweden, Bio-Works contributes significantly to the biotechnology ecosystem by advancing purification technologies, thereby enabling increased efficiency and effectiveness in scientific research and industrial applications. Through continual innovation and application of its expertise, the company supports critical drug development processes, contributing to the advancement of personalized medicine and overall healthcare solutions worldwide. Bio-Works Technologies AB exemplifies a successful integration of advanced biotechnology and industrial application, ensuring high standards and innovation in the global bio-manufacturing landscape.
Markedsdata leveret af TwelveData og Morningstar